Abstract
In present research we have studied the eff ect of docetaxel in ultralow concentrations (0.1-10 nM) and recombinant human beta-defensin-2 (hBD-2) in nanomolar concentration range on proliferation and viability of anaplastic thyroid carcinoma cells of KTC-2 line, and expression of some cell cycle regulatory factors. It has been shown that docetaxel, hBD-2 and combination of these agents signif cantly inhibited proliferation of KTC-2 cells via down-regulation of the cyclin E expression.
Downloads
Download data is not yet available.